Turkish Validation of the Rapprich Lipedema Symptomatic Assessment Questionnaire
ConditionLipedema
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-75
SponsorMarmara University
About this trial
Lipedema is a chronic disease characterized by abnormal fat accumulation, primarily in the lower extremities, affecting women. This study aims to evaluate the validity and reliability of the Turkish version of the Rapprich Lipedema Symptomatic Assessment Questionnaire, which was originally developed by Rapprich et al. in 2010. Since a validated Turkish version is currently unavailable, this research will provide a standardized tool for clinicians to assess symptomatic severity in Turkish-speaking lipedema patients.
Eligibility criteria
Qualifiers
Female patients aged 18-75.
Diagnosed with lipedema by a clinician.
Willingness to participate and sign the informed consent form.
Disqualifiers
Positive Stemmer sign or presence of advanced-stage lymphedema.
Diagnosis of Heart Failure.
Chronic Kidney Disease.
Pregnancy.
Trial design
Treatments tested in this trial
- Questionnaires
- Physical Examination and Functional Testing
Treatment groups
180 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov